Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis

Ethan Craig, Laura C. Cappelli

Research output: Contribution to journalReview article

Abstract

Gastrointestinal (GI) manifestations of rheumatoid arthritis (RA) are rare, but can be impactful for patients. Some GI processes are directly related to RA, whereas others may be sequelae of treatment or caused by concomitant autoimmune diseases. This article discusses the role of the GI tract in RA pathogenesis; the presentation, epidemiology, and diagnosis of RA-related GI manifestations; concomitant GI autoimmune diseases that may affect those with RA; and GI side effects of RA treatment. The importance of appropriately considering conditions unrelated to RA in the differential diagnosis when evaluating new GI symptoms in patients with RA is noted.

LanguageEnglish (US)
Pages89-111
Number of pages23
JournalRheumatic Disease Clinics of North America
Volume44
Issue number1
DOIs
StatePublished - Feb 1 2018

Fingerprint

Gastrointestinal Diseases
Rheumatoid Arthritis
Liver
Autoimmune Diseases
Gastrointestinal Tract
Epidemiology
Differential Diagnosis
Therapeutics

Keywords

  • Antirheumatic medications (DMARDs)
  • Gastrointestinal disease
  • Hepatic disease
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis. / Craig, Ethan; Cappelli, Laura C.

In: Rheumatic Disease Clinics of North America, Vol. 44, No. 1, 01.02.2018, p. 89-111.

Research output: Contribution to journalReview article

@article{0abdf658b06642ebb3967d9ae0e13778,
title = "Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis",
abstract = "Gastrointestinal (GI) manifestations of rheumatoid arthritis (RA) are rare, but can be impactful for patients. Some GI processes are directly related to RA, whereas others may be sequelae of treatment or caused by concomitant autoimmune diseases. This article discusses the role of the GI tract in RA pathogenesis; the presentation, epidemiology, and diagnosis of RA-related GI manifestations; concomitant GI autoimmune diseases that may affect those with RA; and GI side effects of RA treatment. The importance of appropriately considering conditions unrelated to RA in the differential diagnosis when evaluating new GI symptoms in patients with RA is noted.",
keywords = "Antirheumatic medications (DMARDs), Gastrointestinal disease, Hepatic disease, Rheumatoid arthritis",
author = "Ethan Craig and Cappelli, {Laura C.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.rdc.2017.09.005",
language = "English (US)",
volume = "44",
pages = "89--111",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis

AU - Craig,Ethan

AU - Cappelli,Laura C.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Gastrointestinal (GI) manifestations of rheumatoid arthritis (RA) are rare, but can be impactful for patients. Some GI processes are directly related to RA, whereas others may be sequelae of treatment or caused by concomitant autoimmune diseases. This article discusses the role of the GI tract in RA pathogenesis; the presentation, epidemiology, and diagnosis of RA-related GI manifestations; concomitant GI autoimmune diseases that may affect those with RA; and GI side effects of RA treatment. The importance of appropriately considering conditions unrelated to RA in the differential diagnosis when evaluating new GI symptoms in patients with RA is noted.

AB - Gastrointestinal (GI) manifestations of rheumatoid arthritis (RA) are rare, but can be impactful for patients. Some GI processes are directly related to RA, whereas others may be sequelae of treatment or caused by concomitant autoimmune diseases. This article discusses the role of the GI tract in RA pathogenesis; the presentation, epidemiology, and diagnosis of RA-related GI manifestations; concomitant GI autoimmune diseases that may affect those with RA; and GI side effects of RA treatment. The importance of appropriately considering conditions unrelated to RA in the differential diagnosis when evaluating new GI symptoms in patients with RA is noted.

KW - Antirheumatic medications (DMARDs)

KW - Gastrointestinal disease

KW - Hepatic disease

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=85035074071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035074071&partnerID=8YFLogxK

U2 - 10.1016/j.rdc.2017.09.005

DO - 10.1016/j.rdc.2017.09.005

M3 - Review article

VL - 44

SP - 89

EP - 111

JO - Rheumatic Disease Clinics of North America

T2 - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 1

ER -